Morgan Stanley Maintains Underweight on Helmerich & Payne, Lowers Price Target to $42
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Daniel Kutz has maintained an 'Underweight' rating on Helmerich & Payne (NYSE:HP) and lowered the price target from $45 to $42.
July 17, 2023 | 1:54 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Morgan Stanley has maintained an 'Underweight' rating on Helmerich & Payne and lowered the price target from $45 to $42.
The 'Underweight' rating maintained by Morgan Stanley indicates a negative outlook for Helmerich & Payne. The lowering of the price target from $45 to $42 suggests that the analyst believes the stock is overvalued at its current price, which could lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100